Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001838192 | SCV001414391 | likely benign | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2024-08-31 | criteria provided, single submitter | clinical testing | |
Ai |
RCV002223934 | SCV002502285 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002406697 | SCV002717942 | uncertain significance | Cardiovascular phenotype | 2020-06-26 | criteria provided, single submitter | clinical testing | The p.Y637C variant (also known as c.1910A>G), located in coding exon 14 of the APOB gene, results from an A to G substitution at nucleotide position 1910. The tyrosine at codon 637 is replaced by cysteine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV001838192 | SCV002781507 | uncertain significance | Hypercholesterolemia, autosomal dominant, type B; Familial hypobetalipoproteinemia 1 | 2021-10-07 | criteria provided, single submitter | clinical testing |